Skip to content

Category: radiation therapySyndicate content

PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer

November 6, 2009

(PHILADELPHIA) A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented

Aiming to avoid damage to neurocognitive areas of the brain during cranial radiation

November 3, 2009

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is

Adapting space-industry technology to treat breast cancer

November 2, 2009

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used

Preventative brain radiation for lung cancer patients: Benefits and risks

November 2, 2009

CHICAGO -- A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the

Undetectable PSA after radiation is possible and predicts good patient outcomes

November 2, 2009

CHICAGO (November 2, 2009)??Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer pat

DNA test could be key to targeting treatments for head and neck cancer

October 5, 2009

It is estimated that more than 7,000 people are diagnosed with head and neck cancer each year in the UK and approximately 3,500 cases result in death. These cancers include tumours of the mouth, lips, throat and voice-box, and some have been linked to the sexually transmitted infection, HPV-16.

Study finds 231 new genes associated with head and neck cancer

October 4, 2009

SAN DIEGO -- A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States.

Previously, only 33 genes were reported associated with head and neck cancer.

SNM urges Congress to support CARE bill

September 29, 2009

Reston, Va. -- SNM is calling on Congress to support the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act (CARE bill), which would ensure that states set minimum education and credentialing standards for nuclear medicine technologists. The bill (H.R. 3652) was introduced Sept. 28 in the U.S. House of Representatives by Rep. John Barrow (D-Ga.).

Identification of highly radiosensitive patients may lead to side effect-free radiotherapy

September 24, 2009

Berlin, Germany: An international group of scientists has taken the first step on the road to targeting radiotherapy dosage to individual patients by means of their genetic characteristics, a radiation oncologist told Europe's largest cancer congress, ECCO 15 -- ESMO 34 [1], in Berlin today (Thursday September 24).

Incomplete radiation therapy common among medicare recipients with head and neck cancer

September 21, 2009

Medicare recipients with head and neck cancer commonly do not complete radiation therapy without interruptions or at all, according to a report in the September issue of Archives of Otolaryngology?Head & Neck Surgery, one of the JAMA/Archives journals.

Space-related radiation research could help reduce fractures in cancer survivors

September 15, 2009

HOUSTON -- (Sept. 15, 2009) -- A research project looking for ways to reduce bone loss in astronauts may yield methods of improving the bone health of cancer patients undergoing radiation treatment.

Embargoed news from Annals of Internal Medicine

September 14, 2009

Early Release:

1. Three Medications Reduce the Risk for Invasive Breast Cancer but Carry Heavy Risks for Adverse Events

Casting out devils

September 8, 2009

In the scientific journal PLoS ONE, Sara Bartels and Siegfried Weiss of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany now show how the bacteria migrate into tumours. A messenger substance from the immune system is the door opener: It makes blood vessels in the cancerous tissue permeable; enabling the bacteria to conquer and destroy the tumour.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.